Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravesical gentamicin for prevention of recurrent multidrug-resistant urinary tract infections
NL-OMON23211Active, not recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Mar 2014
- Modality
- Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Open-label trial of gentamicin in urinary tract infection (UTI) (2 arms), sponsored by Leiden University Medical Center. Primary endpoints: Number of urinary tract infections during first 6 months and Number of urinary tract infections during 12 months total follow-up. Started Mar 2014; status: active, not recruiting.
02
Drugs
gentamicin
03
Conditions
urinary tract infection (UTI)
Beyond the preview
Go deeper on NL-OMON23211.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON23211.